Published in Parkinsonism Relat Disord on July 07, 2012
Update on deep brain stimulation in Parkinson's disease. Transl Neurodegener (2015) 0.82
An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting. PLoS One (2014) 0.81
Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients. PLoS One (2015) 0.80
Mixed effects of deep brain stimulation on depressive symptomatology in Parkinson's disease: a review of randomized clinical trials. Front Neurol (2014) 0.75
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol (2006) 7.32
Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci (2003) 4.06
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
Improvements in speed-based gait classifications are meaningful. Stroke (2007) 3.26
Body-weight-supported treadmill rehabilitation after stroke. N Engl J Med (2011) 2.95
A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg (2010) 2.94
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet (2013) 2.62
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology (2006) 2.58
Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology (2012) 2.34
Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol (2009) 2.29
Effects of task-specific and impairment-based training compared with usual care on functional walking ability after inpatient stroke rehabilitation: LEAPS Trial. Neurorehabil Neural Repair (2013) 2.20
The history of cerebral PET scanning: from physiology to cutting-edge technology. Neurology (2013) 2.04
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol (2002) 1.90
Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol (2007) 1.86
Fugl-Meyer assessment of sensorimotor function after stroke: standardized training procedure for clinical practice and clinical trials. Stroke (2010) 1.83
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord (2007) 1.82
Emergence of canine distemper in Bavarian wildlife associated with a specific amino acid exchange in the haemagglutinin protein. Vet J (2010) 1.65
Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol (2004) 1.63
Protocol for the Locomotor Experience Applied Post-stroke (LEAPS) trial: a randomized controlled trial. BMC Neurol (2007) 1.57
Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology (2009) 1.51
Cold aortic flush and chest compressions enable good neurologic outcome after 15 mins of ventricular fibrillation in cardiac arrest in pigs. Crit Care Med (2010) 1.48
Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease. Mov Disord (2005) 1.47
Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol (2009) 1.45
Therapeutic hypothermia with a novel surface cooling device improves neurologic outcome after prolonged cardiac arrest in swine. Crit Care Med (2008) 1.41
Pearls in patient selection for deep brain stimulation. Neurologist (2007) 1.37
Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest (2008) 1.34
Epigenetic blocking of an enhancer region controls irradiation-induced proapoptotic gene expression in Drosophila embryos. Dev Cell (2008) 1.33
Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord (2013) 1.31
Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol Psychiatry (2010) 1.28
Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return? Arch Neurol (2005) 1.27
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol (2011) 1.27
Impulse control and related disorders in Parkinson's disease: review. Ann N Y Acad Sci (2008) 1.24
Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications. Curr Neurol Neurosci Rep (2007) 1.20
Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord (2010) 1.16
Using voluntary cough to detect penetration and aspiration during oropharyngeal swallowing in patients with Parkinson disease. Chest (2010) 1.16
Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage (2009) 1.16
The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord (2009) 1.15
Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. Parkinsonism Relat Disord (2011) 1.15
A high resolution and high contrast MRI for differentiation of subcortical structures for DBS targeting: the Fast Gray Matter Acquisition T1 Inversion Recovery (FGATIR). Neuroimage (2009) 1.11
Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: preliminary observations. Mov Disord (2008) 1.09
Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health (2011) 1.09
Micrographia and related deficits in Parkinson's disease: a cross-sectional study. BMJ Open (2012) 1.08
Quantitative trait loci for growth trajectories in Populus. Genet Res (2003) 1.08
A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. JAMA Neurol (2013) 1.08
Is traditional reading of the bedside chest radiograph appropriate to detect intraatrial central venous catheter position? Chest (2008) 1.08
Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J Clin Invest (2013) 1.07
Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. Neuroimage (2010) 1.06
Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease. Mov Disord (2007) 1.06
Long-term effect of home telehealth services on preventable hospitalization use. J Rehabil Res Dev (2009) 1.06
Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis (2012) 1.05
Multiple system utilization and mortality for veterans with stroke. Stroke (2006) 1.05
Identification and management of deep brain stimulation intra- and postoperative urgencies and emergencies. Parkinsonism Relat Disord (2009) 1.05
Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using reliable change. Clin Neuropsychol (2008) 1.05
Cognitive declines after deep brain stimulation are likely to be attributable to more than caudate penetration and lead location. Brain (2014) 1.04
Worsening essential tremor following deep brain stimulation: disease progression versus tolerance. Brain (2012) 1.03
Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord (2014) 1.02
Apathy and depression: separate factors in Parkinson's disease. J Int Neuropsychol Soc (2011) 1.02
Ventralis intermedius plus ventralis oralis anterior and posterior deep brain stimulation for posttraumatic Holmes tremor: two leads may be better than one: technical note. Neurosurgery (2005) 1.01
Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment? Parkinsonism Relat Disord (2010) 1.01
Determination of the general public exposure around GSM and UMTS base stations. Radiat Prot Dosimetry (2007) 1.01
Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke (2002) 1.01
Sequential voluntary cough and aspiration or aspiration risk in Parkinson's disease. Lung (2014) 1.00
An SEM approach to continuous time modeling of panel data: relating authoritarianism and anomia. Psychol Methods (2012) 1.00
Abnormal affective startle modulation in individuals with psychogenic [corrected] movement disorder. Mov Disord (2007) 1.00
Rationale, design, and protocol for the prevention of low back pain in the military (POLM) trial (NCT00373009). BMC Musculoskelet Disord (2007) 0.99
Increased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette's syndrome. PLoS One (2012) 0.99
Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study. Anticancer Drugs (2007) 0.99
Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson's disease. Exp Neurol (2008) 0.99
Foot drop stimulation versus ankle foot orthosis after stroke: 30-week outcomes. Stroke (2013) 0.99
Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma. Pediatr Pulmonol (2004) 0.98
Characterizing and identifying risk for falls in the LEAPS study: a randomized clinical trial of interventions to improve walking poststroke. Stroke (2012) 0.98
The temporal pattern of stimulation may be important to the mechanism of deep brain stimulation. Exp Neurol (2013) 0.98
Respiratory muscle strength training: treatment and response duration in a patient with early idiopathic Parkinson's disease. NeuroRehabilitation (2005) 0.97
Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. J Med Chem (2003) 0.97
Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor. Mov Disord (2007) 0.97
Gene therapy for neurological disorders: challenges and future prospects for the use of growth factors for the treatment of Parkinson's disease. Curr Gene Ther (2009) 0.97
Management of deep brain stimulator battery failure: battery estimators, charge density, and importance of clinical symptoms. PLoS One (2013) 0.97
Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome. PLoS One (2012) 0.97
Which dyskinesia scale best detects treatment response? Mov Disord (2013) 0.97
Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder. Neurocase (2010) 0.96
The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Ann N Y Acad Sci (2003) 0.95
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage (2010) 0.95
Generic versus branded pharmacotherapy in Parkinson's disease: does it matter? A review. Parkinsonism Relat Disord (2011) 0.95
Nonmotor manifestations of dystonia: a systematic review. Mov Disord (2011) 0.95
The number and nature of emergency department encounters in patients with deep brain stimulators. J Neurol (2010) 0.95
Psychosis in Parkinson's disease. J Geriatr Psychiatry Neurol (2004) 0.94